— Know what they know.
Not Investment Advice

APLT NASDAQ

Applied Therapeutics, Inc.
1W: -13.6% 1M: -58.5% 3M: -85.7% 1Y: -88.3% 3Y: -87.5% 5Y: -99.6%
$0.10
Last traded 2025-12-31 — delisted
NASDAQ · Healthcare · Biotechnology · $14.9M mcap · 120M float · 13.18% daily turnover · Short 35% of daily vol

Balance Sheet Trends

Total Assets
$87M +58.1% ▲
5Y CAGR: +12.4%
Total Liabilities
$30M -58.8% ▼
5Y CAGR: +13.5%
Shareholders Equity
$57M +432.5% ▲
5Y CAGR: +11.8%
Cash & Investments
$79M +59.1% ▲
5Y CAGR: +15.4%
Total Debt
$3M +259.7% ▲
5Y CAGR: +6.5%
Net Debt
-$77M -55.9% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$57M$54M$17M$50M$79M
Short-Term Investments$39M$27M$14M$0$0
Cash & ST Investments$97M$81M$31M$50M$79M
Net Receivables$505K$0$275K$285K$0
Inventory$0$0$0$3M$0
Other Current Assets$2M$5M$2M-$434K$461K
Total Current Assets$103M$88M$37M$54M$84M
Property, Plant & Equip.$2M$1M$1M$447K$3M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$200K$0$0$253K
Total Non-Current Assets$2M$1M$1M$447K$3M
Total Assets$105M$90M$38M$55M$87M
— Liabilities —
Accounts Payable$640K$9M$5M$2M$4M
Short-Term Debt$1M$789K$622K$310K$0
Deferred Revenue$0$0$0$667K$212K
Other Current Liabilities$3M$987K$25M$56M$7M
Total Current Liabilities$21M$26M$33M$71M$27M
Long-Term Debt$0$0$464K$0$0
Other Non-Current Liab.$0$0$0$759K$0
Total Non-Current Liabilities$1M$891K$878K$797K$2M
Total Liabilities$23M$27M$34M$72M$30M
— Equity —
Common Stock$2K$3K$5K$8K$35K
Retained Earnings-$161M-$266M-$349M-$469M-$574M
Accumulated OCI-$112K-$107K$51K$0$0
Total Stockholders Equity$82M$63M$4M-$17M$57M
Total Liabilities & Equity$105M$90M$38M$55M$87M
— Key Metrics —
Total Debt$3M$2M$2M$777K$3M
Net Debt-$55M-$52M-$15M-$49M-$77M
Total Investments$39M$27M$14M$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms